The Detection of New Adverse Drug Reactions

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

This work covers all the safety aspects of clinical drug development and post-marketing surveillance, as well as the general background to adverse drug reactions and their collection. The chapter on laboratory investigations has been trebled in size and includes new approaches from around the world. There is extensive advice on the collection, storage, retrieval and management of adverse reaction data. The regulations from France, Germany, Japan, Italy, Scandinavia, USA, UK and the EC have been brought up to date. A new chapter on causality assessment has also been written.